Search

Your search keyword '"Cornely, O. A."' showing total 372 results

Search Constraints

Start Over You searched for: Author "Cornely, O. A." Remove constraint Author: "Cornely, O. A." Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
372 results on '"Cornely, O. A."'

Search Results

1. Kernaussagen und Empfehlungen der AWMF-Leitlinie „Medizinisch klinische Diagnostik bei Schimmelpilzexposition in Innenräumen“ – Update 2023

2. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

3. Survival in multiple myeloma and SARS-COV-2 infection through the COVID-19 pandemic: Results from the EPICOVIDEHA registry

4. Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape

5. The mortality of COVID-19 in CML patients from 2020 until 2022: results from the EPICOVIDEHA survey

7. Onkologie

8. Infektiologie

12. Résultats par pathogènes en baseline et sensibilité dans l'essai de phase 3 ReSTORE de la rezafungine une fois par semaine vs caspofungine une fois par jour chez les patients atteints de candidémies et/ou de candidose invasive.

13. A second update on mapping the human genetic architecture of COVID-19

14. Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry

15. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry

16. Nirmatrelvir/ritonavir in COVID-19 patients with haematological malignancies: a report from the EPICOVIDEHA registry

17. Clinical features and prognostic factors of Magnusiomyces (Saprochaete) infections in haematology. A multicentre study of SEIFEM/Fungiscope

18. Molnupiravir compared to nirmatrelvir/ritonavir for COVID-19 in high-risk patients with haematological malignancy in Europe. A matched-paired analysis from the EPICOVIDEHA registry

19. SARS-CoV-2 Infection In Patients With Mastocytosis: An EPICOVIDEHA Report

20. Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey

21. Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings

22. P22 Patient-level meta-analysis of efficacy and safety from STRIVE and ReSTORE: randomized, double-blinded, multicentre Phase 2 and Phase 3 trials of rezafungin in the treatment of candidaemia and/or invasive candidiasis

24. Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

26. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

28. Infektiologie

29. Onkologie

31. S280: B-CELL MALIGNANCIES TREATED WITH TARGETED DRUGS AND SARS-COV-2 INFECTION. A EUROPEAN HEMATOLOGY ASSOCIATION SURVEY (EPICOVIDEHA)

32. S281: PRIOR EXPOSURE TO IMMUNOSUPPRESSIVE AGENTS AND COMORBIDITIES ARE ASSOCIATED WITH WORSE OUTCOMES OF SARS-COV2 INFECTION IN PH-NEG CHRONIC MYELOPROLIFERATIVE NEOPLASMS: RESULTS OF EPICOVIDEHA SURVEY

34. P1576: A PHASE 3 RANDOMIZED, DOUBLE-BLIND, COMPARATOR-CONTROLLED STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF V114 PNEUMOCOCCAL VACCINE IN HEMATOPOIETIC CELL TRANSPLANT RECIPIENTS (PNEU-STEM)

35. Liposomal amphotericin B-the future

36. Performance of existing definitions and tests for the diagnosis of invasive aspergillosis in critically ill, non-neutropenic, adult patients: An update including COVID-19 data

37. B-cell malignancies treated with targeted drugs and SARS-CoV-2 infection: A European Hematology Association Survey (EPICOVIDEHA)

38. COVID-19 and hairy-cell leukemia: An EPICOVIDEHA survey

39. Simultaneous Onset of Haematological Malignancy and COVID: An Epicovideha Survey

40. Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report

41. Detailed stratified GWAS analysis for severe COVID-19 in four European populations

46. Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples

Catalog

Books, media, physical & digital resources